Pediatric premature atrial contractions: Clinical characteristics, diagnosis, and management—A literature review Authors: Ruihua Yu, Jianhong Qi, Xiaokang Wang Published: 2026 ABSTRACT AbstractBackgroundPremature Atrial Contractions (PACs) are among the most prevalent arrhythmias in the pediatric population, occurring from the fetal period through adolescence. While typically benign in children with structurally normal hearts, PACs carry significant clinical implications for patients with Congenital Heart Disease (CHD), genetic cardiomyopathies, and specific syndromic conditions. This review aims to clarify the clinical characteristics, diagnostic criteria, and management strategies for pediatric PACs.MethodsA comprehensive review of the current literature was conducted regarding the epidemiology, etiology, diagnosis, and management of PACs in pediatric patients. This review synthesizes data from recent meta-analyses, observational studies, and clinical guidelines to establish age-stratified reference limits and risk stratification protocols.ResultsIn healthy school-aged children, the prevalence of PACs ranges from 0.11% to 0.515%, with significantly higher rates observed during the neonatal period. Recent meta-analysis data defines age-stratified reference limits for 24-h ambulatory electrocardiographic (Holter) monitoring: a maximum of 150 PACs per day for neonates and infants (0–12 months) and 50 PACs per day for older children. While fetal PACs generally resolve spontaneously, blocked PACs may rarely progress to sustained tachyarrhythmias. Diagnosis primarily relies on 12‑lead electrocardiography (ECG) and Holter monitoring. Clinically, frequent or non-conducted PACs may cause “pseudo-bradycardia,” occasionally requiring pharmacological intervention with agents such as propafenone. The incidence of PACs is notably increased in children with CHD or following interventional procedures.ConclusionsPACs are predominantly benign in children with structurally normal heartsyet comprehensive evaluation is mandated for patients with symptomatic frequent PACs concurrent structural heart disease or significant electrocardiographic abnormalities. Management should be guided by age-specific reference limits and the underlying cardiac substrateKeywords: Premature atrial contractions, Fetal arrhythmia, Holter monitoring, Electrocardiography, Pseudo-bradycardia, Radiofrequency ablation Introduction Premature Atrial Contractions (PACs) are defined as abnormal electrical impulses originating from the atrial myocardium outside the sinoatrial node and constitute a frequent finding in the evaluation of pediatric arrhythmias [1]. These ectopic beats arise from enhanced automaticity, triggered activity, or re-entry circuits within the atrial tissue and result in premature depolarization of the atria before the next expected sinus beat. While the incidence of PACs in healthy children and adolescents has been extensively studied, reported prevalence rates and diagnostic criteria vary significantly depending on the age of the cohort and the screening modalities employed [2]. Accurately defining reference ranges for rhythm parameters in healthy populations is critical to preventing the misclassification of normal physiological variance as pathological arrhythmia [3]. This distinction holds particular importance in pediatrics, where the developing cardiac conduction system exhibits age-dependent electrophysiological properties that influence the occurrence and clinical significance of ectopic activity. The clinical relevance of PACs exists along a spectrum: from incidental findings in otherwise healthy children requiring no intervention, to harbingers of more significant arrhythmias in susceptible populations. According to a systematic meta-analysis of 24-hour Holter monitoring data in healthy populations, the cumulative prevalence of any atrial ectopic activity in neonates (birth to 4 weeks) reaches 27% [3]. This relatively high prevalence reflects the electrophysiological immaturity of the neonatal conduction system and the transitional hemodynamics of the postnatal period. Screening studies in school-aged children demonstrate that the overall prevalence of rhythm disturbances increases with age; the prevalence in junior high school students (mean age 12.4 years) is 2.32%, compared to 1.25% in elementary school students (mean age 6.4 years). Specifically, the prevalence of PACs is higher in the older cohort (0.158%) than in the younger group (0.067%). Furthermore, gender disparities exist in healthy children, with females generally exhibiting a higher prevalence of PACs (0.123%) compared to males (0.089%) [2]. In the context of Congenital Heart Disease (CHD), arrhythmias, including PACs, are significant contributors to morbidity and mortality. The anatomical abnormalities inherent to CHD, surgical scarring from corrective procedures, and chronic hemodynamic stress collectively predispose these patients to atrial ectopy and more complex arrhythmias. Failure to diagnose and treat these rhythm disturbances early can exacerbate clinical outcomes [4]. Consequently, a comprehensive review of the literature regarding the clinical characteristics, diagnostic criteria, prognostic stratification, and management strategies for pediatric PACs is essential for guiding clinical practice. Methods A comprehensive literature search was conducted across the PubMed, Embase, and Scopus databases for articles published between January 2000 and May 2025. The search strategy employed keywords including “premature atrial contractions,” “pediatric arrhythmia,” “fetal arrhythmia,” and “Holter monitoring reference limits.” This review synthesizes data from recent meta-analyses, observational studies, and clinical guidelines according to PRISMA principles. Inclusion criteria were restricted to peer-reviewed original research and systematic reviews focusing on patients from the fetal period to 18 years of age, while non-English publications and isolated case reports with limited clinical data were excluded. Epidemiology and age-stratified reference values Prevalence in healthy pediatric populations Establishing normative data is essential for clinical decision-making, as it enables clinicians to distinguish pathological ectopy from physiological variation. The prevalence of PACs varies considerably across age groups, reflecting the evolving electrophysiology of the developing heart. A systematic meta-analysis examining Holter rhythm parameters in healthy infants, children, and adolescents (aged <19 years) has established age-stratified reference limits for PAC frequency. The data suggests a daily maximum of 150 PACs for neonates (birth to 4 weeks) and older infants (1–12 months). For young children (1–6 years), older children (7–12 years), and adolescents (13–18 years), the reference limit is lower, set at 50 PACs per day. Notably, the presence of any atrial couplets is considered outside the reference range for all age groups [3]. In the neonatal period specifically, while the cumulative incidence of any PACs is 27%, a frequency exceeding 150 PACs per day occurs in only 2.5% of the population. This observation underscores the predominantly benign nature of neonatal atrial ectopy while providing a threshold above which further investigation may be warranted. Clinicians are advised to regard values exceeding these age-related 95% reference limits as potentially abnormal, warranting clinical correlation and further investigation to determine their significance. It is important to acknowledge that the current 95% reference limits are derived from studies exhibiting significant heterogeneity in sample size, geographic location, and ethnic composition. This variability may influence the accuracy of the proposed thresholds when applied to diverse global populations with differing intrinsic autonomic tones or genetic backgrounds. Because these values predominantly rely on retrospective data, clinicians should apply them with caution, recognizing that the generalizability of a 150 PACs per day limit for infants or 50 for older children may not be universal across all ethnic groups. Fetal prevalence Fetal arrhythmias occur in approximately 1–2% of pregnancies, with PACs representing the most common type, accounting for up to 80–90% of all fetal arrhythmias [5]. A large cohort study examining the natural course of fetal PACs demonstrated that the majority resolve spontaneously before or shortly after birth [5]. However, approximately 1–2% of fetuses with PACs may progress to sustained supraventricular tachycardia, particularly when blocked PACs constitute a significant proportion of atrial ectopy [6]. Risk factors for adverse outcomes in fetal PACs include the presence of structural heart disease, persistence of frequent blocked PACs, and detection in the late third trimester [5]. Gender and age variations Gender-based differences in PAC prevalence have been documented in large population-based studies. Among healthy school-aged children, females demonstrate a higher prevalence of PACs (0.123%) compared to males (0.089%) [2]. The mechanisms underlying this gender disparity remain incompletely understood but may relate to differences in autonomic tone, hormonal influences, or intrinsic atrial electrophysiology. Additionally, prevalence increases with age during childhood: junior high school students exhibit approximately double the prevalence of rhythm disturbances compared to elementary school students [2]. Etiology and risk factors The etiology of pediatric PACs is multifactorial, encompassing structural, congenital, genetic, pharmacological, metabolic, and autonomic factors. Understanding these diverse etiologies is essential for appropriate risk stratification and management. Structural and congenital heart disease Structural and congenital heart diseases are prominent causes of pediatric PACs, often stemming from congenital anomalies of the specialized conduction system or secondary to hemodynamic stress [4]. Atrial enlargement, pressure overload, and volume overload can all promote atrial ectopy through stretch-induced alterations in atrial electrophysiology. In a study of children below 15 years with CHD, arrhythmias were significant contributors to morbidity, with PACs frequently identified among the spectrum of rhythm disturbances [4]. Genetic conditions and cardiomyopathies Specific genetic conditions are also implicated in the development of PACs. The prevalence of PACs in children with Anderson-Fabry Disease is approximately 8%, reflecting the cardiac involvement characteristic of this lysosomal storage disorder [7]. In Duchenne Muscular Dystrophy (DMD), which is characterized by progressive fibrofatty replacement of myocardium, arrhythmias including atrial ectopy are noted, although statistical analysis of non-sustained atrial fibrillation/flutter has been limited by small sample sizes in extant studies [8]. The myocardial fibrosis and structural remodeling inherent to DMD create an arrhythmogenic substrate that promotes ectopic activity. In neonates, rare cases of severe Dilated Cardiomyopathy (DCM) caused by compound heterozygous variants in the RPL3L gene have been associated with occasional PACs and first-degree atrioventricular block [9]. Additionally, children with SCN5A mutations may present with incessant atrial and ventricular ectopy or tachycardia, reflecting the critical role of sodium channel function in cardiac rhythm stability [10]. Beyond sodium channel mutations, the molecular landscape of atrial ectopy involves complex interactions in potassium channel function and calcium handling. For instance, variants in the KCNH2 gene or mutations affecting RYR2 proteins can facilitate delayed after depolarizations, creating a fertile substrate for ectopic triggers. Additionally, metabolic storage within the atrial syncytium, as seen in Anderson-Fabry disease, directly alters electrophysiological properties, promoting re-entrant circuits that further predispose pediatric patients to persistent atrial extrasystoles. Pharmacological and metabolic factors Pharmacological and metabolic factors significantly influence atrial ectopy. In children with CHD, digoxin use has been associated with an increased risk of PACs (95% CI 1.7–7.6), likely related to the drug's effects on intracellular calcium handling and automaticity [11]. Prenatal exposure to cocaine is known to increase the incidence of both atrial and ventricular extrasystoles, with affected neonates demonstrating persistent arrhythmias including frequent blocked PACs [11]. Metabolic disturbances may also manifest with ECG abnormalities; for instance, QTc prolongation has been documented in a neonate with Medium-Chain Acyl-CoA Dehydrogenase (MCAD) deficiency whose mother had a history of atrial and ventricular premature beats during pregnancy [12]. Electrolyte imbalances, particularly hypokalemia and hypomagnesemia, can also precipitate atrial ectopy in the pediatric population, although specific studies in children are limited. Anatomical variants Anatomical variants such as the Chiari network, a reticulated structure in the right atrium representing an embryological remnant, are typically asymptomatic but can be associated with thromboembolism or right atrial pathology. Children with a Chiari network exhibit significant differences in P-wave duration, amplitude, and dispersion compared to controls, suggesting altered atrial conduction that may predispose them to atrial arrhythmia [13]. These P-wave abnormalities reflect heterogeneous atrial activation patterns that could facilitate re-entrant arrhythmias. Autonomic factors and sleep-disordered breathing Autonomic factors and sleep-disordered breathing represent additional contributors to pediatric PACs. In children with Obstructive Sleep Apnea (OSA) undergoing polysomnography, while Premature Ventricular Contractions (PVCs) are the most common ECG abnormality, 8% of children with identified ECG abnormalities—including atrial ectopy—were found to have underlying cardiac pathology requiring further evaluation or treatment [14]. The intermittent hypoxemia, hypercapnia, and autonomic fluctuations characteristic of OSA create conditions favorable for arrhythmogenesis. Clinical presentation Asymptomatic presentation In the pediatric population, PACs are frequently asymptomatic and may be incidental findings during routine physical examinations [11], presenting as an irregular heart rhythm or apparent bradycardia [15]. During auscultation, PACs may produce an irregular rhythm with varying intensity of heart sounds, depending on the timing of the premature beat and the resultant ventricular filling. In many cases, PACs are discovered during routine well-child examinations or sports preparticipation evaluations. Symptomatic manifestations When symptomatic, PACs most commonly manifest as palpitations, with children describing sensations of heart racing, skipped beats, or chest fluttering [7]. The perception of palpitations may be particularly pronounced during quiet periods or before sleep when the child becomes more aware of their heartbeat. In younger children who cannot articulate these sensations, PACs may present with non-specific symptoms such as irritability, feeding difficulties, or apparent discomfort. Pseudo-bradycardia A particularly important clinical presentation involves frequent non-conducted (blocked) PACs mimicking bradycardia, leading to symptoms of dizziness, lightheadedness, or exercise intolerance [16]. When a PAC occurs very early in the cardiac cycle, it may find the atrioventricular node or His-Purkinje system refractory, resulting in failure of ventricular activation. Frequent blocked PACs can reset the sinus node cycle, resulting in a compensatory pause that may be misinterpreted clinically as “pseudo-bradycardia.” This phenomenon is particularly relevant in the evaluation of neonates and infants presenting with apparent bradycardia, where blocked atrial bigeminy should be considered in the differential diagnosis [16]. Electrocardiographic characteristics and diagnosis ECG Features Electrocardiographically, PACs are characterized by a premature P-wave morphology that differs from the sinus P-wave, reflecting the ectopic origin of atrial activation. The P-wave axis and morphology depend on the anatomical location of the ectopic focus: PACs originating from the low right atrium produce inverted P-waves in the inferior leads, while those from the left atrium may demonstrate distinctive morphologies in leads I and aVL. These premature atrial impulses may be followed by a QRS complex that is typically narrow (unless aberrant conduction occurs) or, in the case of non-conducted (blocked) PACs, fail to conduct to the ventricles [16]. The coupling interval—the time between the preceding sinus beat and the PAC—influences both the morphology of the conducted beat and the likelihood of conduction block. Very early PACs may encounter refractoriness in the conduction system, while those occurring later in diastole conduct normally. The post-ectopic pause following a PAC is typically non-compensatory (less than twice the sinus cycle length), distinguishing PACs from most premature ventricular contractions. Diagnostic modalities The diagnostic evaluation typically involves a standard 12‑lead ECG and 24-hour ambulatory (Holter) monitoring [17]. The 12‑lead ECG serves as the primary screening tool, with standard criteria adapted for age-specific normal values. Careful attention to P-wave morphology, timing, and the presence of non-conducted beats is essential. Holter monitoring is utilized to assess heart rate variability, rhythm patterns, and to quantify the burden of ectopy [3]. Some studies define occasional atrial ectopy as fewer than 15 beats per hour. The 24-hour monitoring period allows detection of intermittent arrhythmias that may not be captured on a standard ECG and provides a comprehensive assessment of ectopic burden. Holter monitoring is also instrumental in the longitudinal assessment of postoperative arrhythmias and in evaluating the response to antiarrhythmic therapy. For intermittent symptoms not captured by Holter monitoring, event recorders or extended monitoring devices may be employed. Echocardiography plays a complementary role in excluding structural heart disease, particularly in patients with frequent PACs or concerning clinical features. Fetal diagnosis In the fetal period, PACs are typically detected during routine obstetric auscultation or ultrasonography as an irregular fetal heart rhythm. Fetal echocardiography with M-mode and pulsed Doppler imaging allows precise characterization of the arrhythmia, distinguishing PACs from more concerning rhythms such as supraventricular tachycardia or heart block [5]. The identification of blocked versus conducted PACs has prognostic implications, as a high proportion of blocked PACs may indicate risk for progression to sustained tachyarrhythmias. Prognosis and natural history Benign prognosis in structurally normal hearts The natural history of PACs in children with structurally normal hearts is overwhelmingly benign, particularly in neonates. A study of 109 term infants referred for Holter monitoring due to extrasystoles found that only 7 (6.4%) had “significant arrhythmias” if the resting 12‑lead ECG was normal [18]. This finding supports a conservative approach to neonatal extrasystoles when the baseline ECG and clinical examination are unremarkable. Long-term follow-up studies in children and adolescents with structurally and functionally normal hearts have provided reassuring data regarding the prognosis of asymptomatic atrial ectopy [19]. In a study examining the presentation and prognosis of excessive asymptomatic atrial ectopy in this population, the majority of patients demonstrated stable or decreasing ectopic burden over time without progression to clinically significant arrhythmias [19]. These findings support the benign nature of isolated PACs in healthy children. Fetal outcomes Fetal PACs demonstrate an excellent natural history, with the vast majority resolving spontaneously. A comprehensive study of fetal PACs found that most resolve before birth or within the first weeks of life [5]. However, the study also identified a small subset (approximately 1–2%) that progressed to sustained supraventricular tachycardia, underscoring the importance of appropriate surveillance, particularly for frequent or blocked PACs [5], [6]. Factors associated with adverse outcomes include structural cardiac abnormalities, very frequent PACs (>10% of heartbeats), and persistence into the late third trimester. Situations requiring intervention However, specific clinical scenarios mandate intervention or close surveillance. Frequent non-conducted PACs can result in symptomatic bradycardia necessitating management [7], [16]. The association with OSA is also notable; nearly 10% of children with OSA and ECG abnormalities on polysomnography are diagnosed with cardiac pathology requiring intervention, justifying cardiology referral in this subset [14]. In patients with isolated Congenital Complete Heart Block (CCHB), the emergence of frequent, multiform, or repetitive ectopy, alongside QRS or QTc prolongation or cardiomegaly, is considered an indication for pacemaker implantation, reflecting the principle that rhythm abnormalities accompanied by severe ECG or structural deviations warrant intervention [20]. While long-term prognostic data specifically for healthy children with PACs is evolving, adult data demonstrating associations between excessive supraventricular ectopic activity and increased risk of atrial fibrillation and stroke highlights the importance of establishing longitudinal follow-up protocols [19]. Management Management strategies are stratified based on symptomatology, ectopic burden, and the presence of structural heart disease or other risk factors. Conservative management For asymptomatic children with structurally normal hearts and PAC frequency within reference limits, observation and periodic follow-up are the standard of care [3]. Reassurance of parents and patients regarding the benign nature of the condition is an important component of management. In term neonates with a normal ECG and no evidence of structural heart disease, isolated premature beats rarely necessitate repeat 24-hour Holter monitoring [18]. This approach minimizes unnecessary testing and associated parental anxiety while maintaining appropriate clinical vigilance. Lifestyle modifications may be considered in older children and adolescents, including reduction of caffeine intake, adequate sleep hygiene, and stress management, although evidence for these interventions specifically for pediatric PACs is limited. Indications for further evaluation Conversely, children identified with ECG abnormalities during OSA evaluation should undergo cardiological consultation due to the higher yield of detectable pathology [14]. Similarly, PACs occurring in the context of known or suspected CHD, genetic cardiomyopathies, or significant symptoms warrant comprehensive cardiac evaluation including echocardiography and potentially more extensive arrhythmia monitoring. Pharmacological therapy Pharmacological intervention is generally reserved for symptomatic patients or those with high-risk cardiac pathology. Propafenone, a class IC antiarrhythmic agent, has been reported as safe and effective in suppressing frequent non-conducted PACs that cause symptomatic bradycardia, thereby increasing the average heart rate [16]. The mechanism involves suppression of the ectopic focus through sodium channel blockade. In complex cases, such as children with SCN5A mutations presenting with incessant atrial and ventricular ectopy or tachycardia, combination antiarrhythmic therapy (e.g., amiodarone and propranolol) may be required, even in the neonatal period [10]. The selection of antiarrhythmic therapy in the pediatric setting requires a nuanced comparison of efficacy and safety profiles, prioritized by the specific cardiac substrate and age-related pharmacokinetics. Propafenone is generally highly effective for suppressing symptomatic ectopic foci in patients with structurally normal hearts, though it must be avoided in those with significant CHD due to proarrhythmic risks. In contrast, beta-blockers like propranolol offer a safer profile for reducing sympathetic triggers, especially in genetic syndromes, while amiodarone remains the most potent option for refractory cases despite its well-documented long-term thyroid and pulmonary toxicities. As summarized in Table 1, a direct comparison of these agents is essential for guiding clinical decisions, particularly when balancing the suppression of ectopic focus against the risk of proarrhythmia in children with underlying structural heart disease or genetic channelopathies. Table 1Comparative efficacy and safety of antiarrhythmic agents in pediatric PACs.AgentClassPrimary pediatric indicationCommon adverse effectsPropafenoneICSymptomatic “pseudo-bradycardia” and frequent PACsProarrhythmia, gastrointestinal distress, metallic tastePropranololIIPACs associated with genetic syndromes or catecholamine triggersBradycardia, hypotension, bronchospasm, hypoglycemiaAmiodaroneIIIRefractory or incessant atrial ectopy and tachycardiaThyroid dysfunction, pulmonary toxicity, corneal deposits Comparative efficacy and safety of antiarrhythmic agents in pediatric PACs. Catheter ablation Radiofrequency catheter ablation is rarely indicated for PACs in isolation given their benign nature in most pediatric patients. However, ablation becomes a viable therapeutic option if PACs trigger sustained or symptomatic Supraventricular Tachycardia (SVT), acting as initiating triggers for re-entrant arrhythmias. Catheter ablation is also utilized for arrhythmias associated with CHD [21]. Specifically, in patients who have undergone the Mustard or Senning procedures for D-Transposition of the Great Arteries (D-TGA), changes in the electrophysiology of atrioventricular nodal reentrant tachycardia may occur, for which ablation is a recognized treatment modality [21]. Advances in mapping technology and ablation techniques have improved safety and efficacy in pediatric patients. Special populations Fetal PACs Fetal arrhythmias represent a unique clinical scenario requiring specialized diagnostic and management approaches. PACs are the most common fetal arrhythmia, accounting for the majority of irregular fetal heart rhythms detected during routine prenatal care [1], [5]. Gordon et al. demonstrated that fetal PACs during the second and third trimester are not associated with alterations in fetal breathing patterns, suggesting preserved fetal well-being in most cases [1]. The natural history is favorable, with spontaneous resolution occurring in the majority of cases [5], [6]. However, surveillance is warranted for frequent or blocked PACs, as approximately 1–2% may progress to sustained supraventricular tachycardia [5], [6]. Serial fetal echocardiography is recommended to monitor for signs of tachycardia-mediated cardiomyopathy or hydrops fetalis in high-risk cases. Prenatal counseling should emphasize the generally excellent prognosis while acknowledging the small risk of arrhythmia progression. Maternal cocaine use represents a specific risk factor for persistent fetal and neonatal arrhythmias. Prenatal exposure to cocaine is associated with increased incidence of both atrial and ventricular extrasystoles, with affected infants demonstrating persistent arrhythmias including frequent blocked PACs into the neonatal period [11]. Neonates and infants Neonates represent a unique cohort where PACs are both common and typically benign, with a prevalence of 27% in the first four weeks of life [3]. The relatively high prevalence reflects the electrophysiological immaturity of the neonatal heart and the transitional circulation of the postnatal period. In Very Low Birth Weight (VLBW) preterm infants, non-sinus atrial rhythm is the most common cause of non-sinus bradycardia, followed by junctional escape rhythm [22]. This finding has implications for the evaluation of bradycardia in the neonatal intensive care unit. Significant neonatal arrhythmias are defined by thresholds such as PACs exceeding 10% of total heart beats [18]. This quantitative criterion helps distinguish clinically significant ectopy from the expected physiological variation in healthy neonates. For term neonates with extrasystoles, a normal resting ECG, and absence of structural heart disease, the prognosis is excellent and repeat Holter monitoring is generally not required [18]. Children with congenital heart disease Children with CHD face a higher risk of non-benign arrhythmias, particularly following surgical repair. The anatomical abnormalities, surgical scarring, and hemodynamic sequelae of CHD create an arrhythmogenic milieu that promotes atrial ectopy. Specifically, in patients with an Atrial Septal Defect (ASD), the chronic volume overload resulting from a left-to-right shunt causes progressive right atrial stretch. This mechanical stress induces profound structural and electrical remodeling of the atrial myocardium, establishing a direct physiopathological linkage to heart rhythm disorders and predisposing these patients to PACs as well as more complex supraventricular arrhythmias [23]. Long-term follow-up (10.5 years) of patients post-Arterial Switch Operation (ASO) revealed occasional atrial ectopy in 20.0% [17]. This observation underscores the importance of ongoing arrhythmia surveillance in this population. Following transcatheter closure of secundum ASD, the incidence of arrhythmias—including PACs and various degrees of block—is approximately 1.1% [21]. In a cohort of 651 children, 4.5% developed occasional PACs within 24 h of device closure, which resolved spontaneously after one day [24]. The transient nature of these arrhythmias suggests a relationship to procedural factors rather than permanent conduction system injury. The ratio of the occluder size to the atrial septal length (ASO/ASL) may serve as a predictor for post-procedural arrhythmias, with larger device-to-septum ratios potentially indicating higher risk [25]. This metric may assist in procedural planning and post-procedure monitoring strategies. In patients with CHD, the prognostic role of PACs remains a subject of ongoing debate. It is unclear whether these ectopic beats serve as independent predictors of future adverse events or merely represent secondary markers of myocardial remodeling and hemodynamic stress. Consequently, while PACs in CHD patients necessitate vigilant monitoring, further research is required to determine if their presence alone should fundamentally alter the established management algorithms for underlying cardiac conditions or surgical follow-up. Genetic syndromes and cardiomyopathies Children with specific genetic syndromes and cardiomyopathies require individualized surveillance and management. In Anderson-Fabry Disease, the 8% prevalence of PACs reflects the progressive cardiac involvement characteristic of this condition [7]. Regular cardiac monitoring with ECG and Holter monitoring is recommended as part of comprehensive multidisciplinary care. Children with Duchenne Muscular Dystrophy require routine cardiac surveillance given the inevitable progression to cardiomyopathy. While atrial arrhythmias including PACs may occur, the primary cardiac concerns relate to ventricular dysfunction and life-threatening ventricular arrhythmias [8]. Controversies and future directions Appropriate use criteria for echocardiography The evaluation of asymptomatic patients presents specific challenges regarding resource utilization. The pediatric “Appropriate Use Criteria” (AUC) currently classifies the initial outpatient transthoracic echocardiogram (TTE) as “Appropriate” for asymptomatic patients with an abnormal ECG, including PACs. However, research indicates a low diagnostic yield (6.5%) for TTE in this specific context [26]. ECG findings such as isolated PACs, ectopic atrial rhythm, or sinus bradycardia rarely correlate with abnormal TTE findings unless accompanied by ECG signs suggestive of right heart disease (e.g., incomplete right bundle branch block, right axis deviation, or right ventricular hypertrophy) [26]. Future revisions of the AUC should consider stratifying indications based on specific ECG subtypes to improve resource utilization while maintaining appropriate detection of structural abnormalities. This approach would balance the need for thorough evaluation against the costs and potential anxiety associated with unnecessary testing. To optimize clinical resources and reduce unnecessary parental anxiety, a stratified diagnostic algorithm for the use of TTE is warranted. In this model, TTE is not automatically indicated for every asymptomatic child with isolated PACs. Instead, structural evaluation should be prioritized only when PACs are accompanied by specific ECG markers, such as right axis deviation, right ventricular hypertrophy, or an ectopic burden exceeding 10% of total heartbeats. This approach aligns with evidence showing a low diagnostic yield for routine TTE in isolated ectopy while ensuring the detection of significant underlying cardiac pathology. Limitations of current reference data While recent meta-analyses have provided important reference limits for Holter parameters in healthy children, several limitations warrant consideration. Current data does not include prevalence information for sustained supraventricular tachycardia, atrial fibrillation, or high-grade atrioventricular block in the general pediatric population, limiting the ability to contextualize these findings when encountered clinically. Additionally, the existing reference limits rely predominantly on retrospective data derived from heterogeneous studies that vary in sample size, geographic location, ethnic composition, monitoring equipment, and inclusion criteria. This heterogeneity may introduce imprecision in the proposed thresholds and limit their generalizability across diverse populations. Furthermore, most available studies lack standardized definitions for ectopic burden quantification, and few have correlated Holter findings with long-term clinical outcomes, making it difficult to determine which deviations from reference values carry true prognostic significance. These limitations underscore the need for prospective, multicenter studies employing standardized methodology to establish more robust and universally applicable normative data for pediatric Holter monitoring. Future research priorities Future research should prioritize large-scale, prospective, longitudinal studies stratified by sex, race, and geography to refine normal values and better elucidate which ECG abnormalities in asymptomatic children genuinely necessitate structural cardiac evaluation. Specific areas requiring investigation include the long-term outcomes of children with excessive asymptomatic PACs to determine if early intervention alters prognosis, optimal surveillance protocols for fetal PACs including frequency of monitoring and criteria for escalation, genetic determinants of atrial ectopy in pediatric populations, development and validation of risk stratification tools for identifying children with PACs who may benefit from closer surveillance, and comparative effectiveness of different antiarrhythmic agents in symptomatic pediatric patients. Additionally, advances in wearable cardiac monitoring technology may enable more comprehensive characterization of ectopic burden in the ambulatory setting, potentially refining our understanding of normal versus pathological atrial ectopy in children. Bridging the gap between pediatric observations and adult outcomes requires the implementation of standardized longitudinal follow-up protocols. While the current link between childhood PACs and adult risks, such as atrial fibrillation and stroke, remains speculative, structured monitoring throughout the transition to adulthood is essential. Future research should track high-burden patients from adolescence into their twenties to determine if excessive early ectopy serves as a primary driver of myocardial remodeling, potentially necessitating early preventive interventions that are not currently part of pediatric care standards. Conclusion PACs are a pervasive arrhythmia across the pediatric spectrum from the fetal period through adolescence. In healthy children with structurally normal hearts PACs are predominantly benign with excellent long-term prognosis and clinical evaluation must be guided by age-stratified reference standards such as the upper limit of 150 PACs per day for infants and 50 PACs per day for older children. However clinical significance is markedly elevated when PACs provoke symptoms such as pseudo-bradycardia occur in the context of Congenital Heart Disease or genetic cardiomyopathies or present as frequent or blocked beats in the fetal period with potential for progression to sustained tachyarrhythmias. Diagnosis is anchored by 12‑lead ECG and 24-hour Holter monitoring while management is stratified by symptoms and underlying substrate ranging from observation for asymptomatic patients to pharmacological intervention with agents like propafenone for symptomatic cases with catheter ablation reserved for PACs triggering sustained tachyarrhythmias Future investigative efforts should focus on refining normative Holter data across diverse populations, delineating precise criteria for structural evaluation in asymptomatic children, and establishing evidence-based surveillance protocols for high-risk subgroups. As our understanding of pediatric electrophysiology continues to evolve, these efforts will enable more precise risk stratification and individualized management for children with PACs. CRediT authorship contribution statement Ruihua Yu: Writing – original draft, Methodology, Investigation. Jianhong Qi: Writing – review & editing, Formal analysis, Data curation. Xiaokang Wang: Writing – review & editing, Validation, Project administration. Ethical statement This article is a literature review and does not contain any studies with human participants or animals performed by any of the authors. Therefore, the requirement for Ethical Approval or Informed Consent is not applicable. All sources and literature have been appropriately cited. Funding This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Declaration of competing interest The authors declare no competing interests. The authors received no financial support for the research, authorship, and/or publication of this article. Acknowledgements The authors would like to thank the Department of Neonatal Pediatrics at Shandong Provincial Hospital Affiliated to Shandong First Medical University for their administrative support and guidance during the preparation of this manuscript. References